Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Stroke Medicine, Kawasaki Medical School, Okayama, Japan.
Thromb Haemost. 2022 Mar;122(3):415-426. doi: 10.1055/a-1522-4507. Epub 2021 Jul 6.
Thrombosis is a dynamic process, and a thrombus undergoes physical and biochemical changes that may alter its response to reperfusion therapy. This study assessed whether thrombus age influenced reperfusion quality and outcomes after mechanical thrombectomy for cerebral embolism.
We retrospectively evaluated 185 stroke patients and thrombi that were collected during mechanical thrombectomy at three stroke centers. Thrombi were pathologically classified as fresh or older based on their granulocytes' nuclear morphology and organization. Thrombus components were quantified, and the extent of NETosis (the process of neutrophil extracellular trap formation) was assessed using the density of citrullinated histone H3-positive cells. Baseline patient characteristics, thrombus features, endovascular procedures, and functional outcomes were compared according to thrombus age.
Fresh thrombi were acquired from 43 patients, and older thrombi were acquired from 142 patients. Older thrombi had a lower erythrocyte content ( < 0.001) and higher extent of NETosis ( = 0.006). Restricted mean survival time analysis revealed that older thrombi were associated with longer puncture-to-reperfusion times (difference: 15.6 minutes longer for older thrombi, = 0.002). This association remained significant even after adjustment for erythrocyte content and the extent of NETosis (adjusted difference: 10.8 minutes, 95% confidence interval [CI]: 0.6-21.1 minutes, = 0.039). Compared with fresh thrombi, older thrombi required more device passes before reperfusion ( < 0.001) and were associated with poorer functional outcomes (adjusted common odds ratio: 0.49; 95% CI: 0.24-0.99).
An older thrombus delays reperfusion after mechanical thrombectomy for ischemic stroke. Adding therapies targeting thrombus maturation may improve the efficacy of mechanical thrombectomy.
血栓是一个动态的过程,血栓会发生物理和生化变化,这可能会改变其对再灌注治疗的反应。本研究评估了血栓年龄是否会影响脑栓塞机械取栓后的再灌注质量和结局。
我们回顾性评估了三家卒中中心机械取栓过程中收集的 185 例卒中患者和血栓。根据其嗜中性粒细胞核形态和结构,将血栓病理分类为新鲜血栓或陈旧血栓。定量分析血栓成分,并通过抗瓜氨酸化组蛋白 H3 阳性细胞密度评估 NETosis(中性粒细胞胞外诱捕网形成过程)的程度。根据血栓年龄比较患者基线特征、血栓特征、血管内操作和功能结局。
43 例患者获得新鲜血栓,142 例患者获得陈旧血栓。陈旧血栓的红细胞含量较低( < 0.001),NETosis 程度较高( = 0.006)。受限平均生存时间分析显示,陈旧血栓与更长的穿刺至再灌注时间相关(陈旧血栓长 15.6 分钟, = 0.002)。即使在调整红细胞含量和 NETosis 程度后,这种关联仍然显著(校正差异:10.8 分钟,95%置信区间[CI]:0.6-21.1 分钟, = 0.039)。与新鲜血栓相比,陈旧血栓在再灌注前需要更多的器械通过( < 0.001),与较差的功能结局相关(校正后常见比值比:0.49;95%CI:0.24-0.99)。
陈旧血栓会延迟缺血性卒中机械取栓后的再灌注。增加针对血栓成熟的治疗方法可能会提高机械取栓的疗效。